50 investors, 100 start-ups – Actimi takes first place in the Life Science & Health category
With our product “Telemonitoring for Chronic Heart Failure in the outpatient setting”, we enable physicians to bill for the digital remote monitoring of their patients. This is made possible by an amendment to the regulations from 2022.
Actimi provides the infrastructure for this, consisting of a patient-side app, dashboard and HL7 FHIR server. The use of artificial intelligence enables customized alert notifications when patient health scores deteriorate.
With a three-minute pitch followed by a Q&A session, our CEO Maximilian Weiß was able to convince the expert jury and beat out seven other startups in our category.
The large number of inquiries from interested investors confirms that we are on the right track with our vision. Many thanks to the LMU Entrepreneurship Center for the organization and the opportunity to participate. We wish all participating start-ups good luck for the future.